Minakem Generic APIs Minakem Generic APIs

X

Find the latest news about Sanofi aggregated by PharmaCompass.com.

  • Webinars & Exhibitions

PharmaCompass

https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-eyes-investment-up-16-bln-germany-handelsblatt-says-2024-07-01/

REUTERS
01 Jul 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-verona-pharmas-therapy-smokers-lungs-2024-06-26/

REUTERS
27 Jun 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-backed-formation-bio-raises-372-million-late-stage-funding-round-2024-06-26/

REUTERS
27 Jun 2024

https://www.fiercepharma.com/pharma/sanofi-spinoff-euroapi-telegraphs-2-site-sales-and-hundreds-layoffs-it-rolls-ahead

Fraiser Kansteiner FIERCE PHARMA
27 Jun 2024

https://www.pharmabiz.com/NewsDetails.aspx?aid=169990&sid=2

PHARMABIZ
27 Jun 2024

https://www.fiercepharma.com/pharma/sanofi-asks-private-equity-bids-its-consumer-health-unit-bloomberg

FIERCE PHARMA
26 Jun 2024

https://www.fiercebiotech.com/biotech/ai-focused-formation-secures-sanofi-backed-372m-series-d-license-more-drugs

FIERCE BIOTECH
26 Jun 2024

https://www.globenewswire.com/news-release/2024/06/26/2904848/0/en/Dupixent-dupilumab-Positive-Phase-3-Data-in-Children-1-to-11-Years-of-Age-with-Eosinophilic-Esophagitis-Published-in-the-New-England-Journal-of-Medicine.html

GLOBENEWSWIRE
26 Jun 2024

https://www.globenewswire.com/news-release/2024/06/26/2904709/0/en/EUROAPI-is-moving-ahead-with-its-FOCUS-27-plan-setting-the-foundations-for-future-profitable-growth1.html

GLOBENEWSWIRE
26 Jun 2024

https://www.globenewswire.com/news-release/2024/06/25/2904090/0/en/Press-Release-Availability-of-the-Q2-2024-Aide-m%C3%A9moire.html

GLOBENEWSWIRE
25 Jun 2024
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY